Aminolevulinic Acid-Mediated Photodynamic Therapy of Human Meningioma: An in Vitro Study on Primary Cell Lines

Mustafa El-Khatib(Düsseldorf University Hospital), Jan F. Cornelius(Hôpital Lariboisière), Carolin Tepe(Düsseldorf University Hospital), Brigitte Senger(Düsseldorf University Hospital), Walter Stummer(University of Münster), Markus J. Riemenschneider(University Hospital Regensburg), Hans Steiger(Düsseldorf University Hospital), Maxine Dibué(LivaNova (United Kingdom))
International Journal of Molecular Sciences
April 30, 2015
10.3390/ijms16059936
Cited by 37

Related Papers

Fluorescence-guided surgery with 5-aminolevulinic acid for resection of malignant glioma: a randomised controlled multicentre phase III trial
|The Lancet Oncology|2006|3.4k
EXTENT OF RESECTION AND SURVIVAL IN GLIOBLASTOMA MULTIFORME
|Neurosurgery|2008|1k
Fluorescence-guided resection of glioblastoma multiforme utilizing 5-ALA-induced porphyrins: a prospective study in 52 consecutive patients
|Journal of neurosurgery|2000|880
Lomustine-temozolomide combination therapy versus standard temozolomide therapy in patients with newly diagnosed glioblastoma with methylated MGMT promoter (CeTeG/NOA–09): a randomised, open-label, phase 3 trial
|The Lancet|2019|581
What is the Surgical Benefit of Utilizing 5-Aminolevulinic Acid for Fluorescence-Guided Surgery of Malignant Gliomas?
|Neurosurgery|2015|368